Gentium Spa Stock Quote GNT - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Gentium Begins Trading on NASDAQ; New Ticker Symbol: GENT

Gentium S.p.A. (NASDAQ:GENT)(AMEX:GNT) (the Company) today announced that its American Depository Shares (ADSs) will be listed and begin trading today on the NASDAQ National Market System under...

Gentium to Trade on NASDAQ National Market

Gentium S.p.A. (AMEX: GNT) (the Company) today announced that effective May 16, 2006, the Company's American Depository Shares (ADSs) will be listed for trading on The NASDAQ National Market...

Gentium Reports 2005 Financial Results; Provides Financial and Clinical Update

Gentium S.p.A. (AMEX:GNT) (the "Company") today reported financial results for the quarter and year ended December 31, 2005. Highlights of the fourth quarter of 2005 and recent weeks as of...

Gentium Receives First IRB Approval to Begin U.S. Phase III Trial with Defibrotide to Treat Veno-Occlusive Disease with Multipl

Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Beth Israel Deaconess Medical Center and The Children's Hospital Receive IRB Approval to Commence Study ? Gentium S.p.A...

Gentium to Present at Angiogenesis in Cancer and Vascular Disease Congress; Defibrotide Has Anti-Angiogenic Properties In Vitro

Gentium S.p.A. (AMEX:GNT) (the "Company") today reported that on February 7, 2006, Guenther Eisser, Chief of Biology Research for Gentium, will present a poster entitled, "Defibrotide...

Gentium's Defibrotide Subject of Independent Study in Japan; First Japanese Study Reports That Defibrotide Shows Success Treatin

Gentium S.p.A. (AMEX:GNT) (the "Company") today reported that an independent study of Defibrotide was the subject of a published paper titled "Successful Treatment with Defibrotide for Sinusoidal...

Gentium Initiates Phase II/III Pediatric Trial with Defibrotide to Prevent Veno-Occlusive Disease; European Group for Blood and

Gentium S.p.A. (AMEX:GNT) (the "Company") today announced the initiation of a Phase II/III trial with Defibrotide to prevent Veno-Occlusive Disease ("VOD"), a complication of bone marrow and stem...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MINFT Limited	$ 6.51 (25.68%)	44.36k
BATLBattalion Oil Corporation	$ 2.97 (16.47%)	49.59k
EFSH1847 Holdings LLC	$ 1.83 (13.66%)	53.59k
JNUGDirexion Daily Junior Gold Miners Index Bull 2X Shares	$ 45.435 (12.88%)	1.77M
BTGB2Gold Corp	$ 3.09 (12.77%)	37.89M
RYDERyde Group Ltd	$ 2.01 (-84.67%)	26.35M
MPUMega Matrix Corp	$ 1.14 (-28.75%)	2.36M
DXFDunxin Financial Holdings Ltd	$ 0.131 (-17.97%)	4.29M
BQBoqii Holding Limited	$ 0.3413 (-16.72%)	915.77k
JDSTDirexion Daily Junior Gold Miners Index Bear 2X Share	$ 28.50 (-13.24%)	1.04M
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 31.81 (-1.27%)	94.61M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	$ 24.54 (1.57%)	54.71M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	$ 7.29 (-2.41%)	51.33M
SPYSPDR S&P 500	$ 559.09 (0.84%)	49.26M
SHProShares Short S&P500 New	$ 11.26 (-0.79%)	41.26M